SCHEMBL873820

SCHEMBL873820

O=C(Nc1ccc(-c2ccc(C(=O)NCCN3CCCCC3)c(Nc3ccccc3)n2)cc1)c1cc2cccnc2s1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ATR Q13535 4/20 0.46
IKBKB O14920 1/20 0.43
CHUK O15111 1/20 0.43
IKBKG Q9Y6K9 1/20 0.43
CHRNA7 P36544 1/20 0.42
MCHR1 Q99705 2/20 0.42
NAMPT P43490 1/20 0.41
CYP3A4 P08684 1/20 0.40
CYP2D6 P10635 1/20 0.40
CYP2C9 P11712 1/20 0.40
KCNH2 Q12809 1/20 0.40
MEN1 O00255 1/20 0.40
POLB P06746 1/20 0.40
KMT2A Q03164 1/20 0.40
JAK2 O60674 1/20 0.40
MCHR2 Q969V1 1/20 0.39
DRD2 P14416 1/20 0.39
DRD3 P35462 1/20 0.39
NPSR1 Q6W5P4 1/20 0.39
TERT O14746 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL874686 0.90 CYP3A4 (0.42) ATRIKBKBCHUKIKBKGCHRNA7
SCHEMBL874515 0.90 ATR (0.43) ATRIKBKBCHUKIKBKGCHRNA7
SCHEMBL875500 0.89 ATR (0.41) ATRIKBKBCHUKIKBKGCHRNA7
SCHEMBL873657 0.89 CYP3A4 (0.41) ATRIKBKBCHUKIKBKGCHRNA7
SCHEMBL874280 0.87 BCHE (0.39) CHRNA7NAMPTMEN1KMT2ANPSR1
SCHEMBL873584 0.85 KMT2A (0.40) NAMPTMEN1KMT2AJAK2NPSR1
SCHEMBL873821 0.83 NAMPT (0.39) CHRNA7NAMPTCYP3A4CYP2D6CYP2C9
SCHEMBL874835 0.82 MEN1 (0.43) CHRNA7MEN1KMT2AJAK2NPSR1
SCHEMBL874151 0.81 CYP3A4 (0.40) ATRCHRNA7MCHR1NAMPTCYP3A4
SCHEMBL874058 0.81 NAMPT (0.42) ATRCHRNA7NAMPTCYP3A4CYP2D6

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2012038905-A1 THIENOPYRIDINE NICOTINAMIDE DERIVATIVES, PREPARATION THEREOF AND THERAPEUTIC USE THEREOF SANOFI (FR) 2012-03-29 WO disclosed